SHYF Company Profile

Shifting our attention towards the fourth quarter of 2022 the Major Pharmaceutical Preparations company lost money at $-0.07 per share, relative to the recent numbers of $-0.56 per share a year before reporting season, In the previous reporting season the Biora Therapeutics Inc realized $-0.03 per share.

As one of many businesses, the Savara Inc reported also the fourth quarter of 2022 effort

The Major Pharmaceutical Preparations industry reporters continue to interpret the fourth quarter of 2022 earnings. Today those reporters monitor operating shortfall of $-10.875 millions, from the SVRA, which has not mentioned any top-line thus far, for the own October to December 31 2022 reporting period.

The Regional Banks company released Sales of $25.456 millions, in the fourth quarter of 2022 earnings season

LNKB proclaimed $25.456 millions, in Sales in the fourth quarter of 2022 earnings season.

Ecb Bancorp Inc released Sales of $16.256 millions, in the most recent fiscal period

the Regional Banks company proclaimed $16.256 millions, in Sales in the fourth quarter of 2022 earnings season.

A loss of $-0.55 per Share at STRO during the fourth quarter of 2022 earnings season

For the fourth quarter of 2022 earnings season company lost money of $-0.55 per share compare to $-0.82 a year before and surged loss from $-0.37 per share from the prior financial reporting period.

Sales receded extensively by -18.979 % to $8.63 millions from $10.65 millions in the same financial reporting period a year before and sequentially Sales Tumbled by -65.674 % from $25.15 millions.